Vani Pharma Labs Profile
Key Indicators
- Authorised Capital ₹ 4.40 Cr
as on 24-12-2024
- Paid Up Capital ₹ 2.65 Cr
as on 24-12-2024
- Company Age 48 Year, 6 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 48.80 Cr
as on 24-12-2024
- Satisfied Charges ₹ 15.34 Cr
as on 24-12-2024
- Revenue 40.44%
(FY 2020)
- Profit 61.30%
(FY 2020)
- Ebitda 55.73%
(FY 2020)
- Net Worth 78.65%
(FY 2020)
- Total Assets 39.43%
(FY 2020)
About Vani Pharma Labs
The Corporate was formerly known as Vani Chemicals & Intermediates Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 4.40 Cr and a paid-up capital of Rs 2.65 Cr.
The company currently has active open charges totaling ₹48.80 Cr. The company has closed loans amounting to ₹15.34 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chakradhar Mallampati, Lakshmi Mallampati, and Kalyan Gadde serve as directors at the Company.
- CIN/LLPIN
U24110TG1976PLC002040
- Company No.
002040
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
15 Jun 1976
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vani Pharma Labs Limited offer?
Vani Pharma Labs Limited offers a wide range of products and services, including Chemical Compound, API (Active Pharmaceutical Ingredients), Antipyretic and Analgesic API, Pesticide Intermediate, Blood Pressure Medicine, Bisoprolol Fumarate Tablet.
Who are the key members and board of directors at Vani Pharma Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chakradhar Mallampati  | Managing Director | 22-Dec-1998 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lakshmi Mallampati | Additional Director | 24-Dec-2021 | Current |
| Kalyan Gadde | Director | 22-Dec-2017 | Current |
Financial Performance of Vani Pharma Labs.
Vani Pharma Labs Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 40.44% increase. The company also saw a substantial improvement in profitability, with a 61.3% increase in profit. The company's net worth Soared by an impressive increase of 78.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vani Pharma Labs?
In 2020, Vani Pharma Labs had a promoter holding of 46.31% and a public holding of 53.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vani Organics Private LimitedActive 40 years 2 monthsChakradhar Mallampati and Kalyan Gadde are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Standard Chartered Bank Creation Date: 09 Jun 2022 | ₹5.00 Cr | Open |
Axis Bank Limited Creation Date: 11 May 2022 | ₹7.50 Cr | Open |
Others Creation Date: 12 Nov 2020 | ₹2.52 Cr | Open |
How Many Employees Work at Vani Pharma Labs?
Unlock and access historical data on people associated with Vani Pharma Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vani Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vani Pharma Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
